Navlimetostat for mesothelioma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 May 2026: Trial registered, NCT07602946

The trials

NCT07602946: SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma

State
Not started
Phase
Phase 2
People
30 planned
Started
11 May 2026
Primary completion
Jul 2027
Arms
A phase II trial of BMS-986504 in patients with MTAP-deficient relapsed mesothelioma
Results
None posted
  1. 22 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.